Patient’s Voice 2021 by CLARINESS

Putting the patient at the center of R&D decision making

Within the last 5 years, the Patient’s Voice conference has developed into one of the most important meeting points in the pharma sector, bringing together patients, pharma industry leaders, responsible study specialists, site professionals and physicians. Due to COVID-19, this year’s Patient’s Voice will be an online event, giving participants the opportunity to have first-hand access to patients’ perspectives, in order to implement them into the drug development process.

Panelists in this webinar will teach participants how to design and implement patient-friendly protocols and feasible clinical trials to successfully recruit, retain and engage patients. Understanding the needs of the patient can ensure that trials complete on time and on budget – the patient needs to be at the center of R&D decision making.

Register for this webinar to take time to listen, learn and understand the patients.

Insights from patients who have participated in clinical trials:

Maria Jackson:

“My experience with taking part in a clinical trial was very good. I know that a lot of people find the idea quite scary and can be easily put off, but for me it was a good experience. The clinical trial helped me with another medical condition that I have that I had tried to get resolved for many years.”

Alec Alexandrou:

“I know that officially you call us ‘subjects’, but you don’t need to make us feel as such. Care should be taken to involve participants more, to interact with them.”

Robert Frankland:

“I have previously suffered cancer of the prostate and am now clear, fit and healthy. I have attended many clinical trials, in general, and I have found my experiences with regards to clinical trials beneficial. Obviously, some trials have been better than others with regards to procedures, medication and the care of patients right after receiving the drugs. The attitude of other volunteers can have an impact on the experience.”

Speakers

Amy Froment, Head of Global Trial Optimization, Regeneron U.K.

Amy Froment is the Head of the Global Trial Optimization Group at Regeneron, partnering with teams to optimize operational trial design and placement through the utilization of innovation and data analytics. A key focus of this group is to centralize efforts to obtain and leverage external expertise from trial participants, disease experts and trial sites in order to align the scientific design of a study with the perspectives of patients and study site staff.

Message Presenter

Dr. Andree Beckerling, CEO, CLARINESS

Andree and his team are committed to delivering valuable patient focused solutions for pharmaceutical, medical device and biotech companies in need of patient recruitment, patient retention and patient insight services. Over the last 20+ years, Andree has served as CEO, CMO, as well as in multiple other executive and operational leadership roles in the CRO industry. During this time, he gained extensive experience while managing and closely supervising numerous clinical development programs in major therapeutic areas across the globe. Andree is a trained MD, PhD, MBA and holds a degree in Pharmaceutical Medicine.

Message Presenter